Community-acquired pneumonia in elderly patients: the effectiveness of antimicrobial therapy regimens.
- 作者: Kulagina I1, Likhodii V1, Zaitsev A1
-
隶属关系:
- Главный военный клинический госпиталь им. Н.Н.Бурденко
- 期: 卷 21, 编号 3 (2019)
- 页面: 60-62
- 栏目: Articles
- URL: https://journals.rcsi.science/1682-7392/article/view/20686
- DOI: https://doi.org/10.17816/brmma20686
- ID: 20686
如何引用文章
全文:
详细
The clinical efficacy of using «protected» aminopenicillins (amoxicillin/clavulanate, amoxicillin/sulbactam) and the 3rd generation cephalosporins in the treatment of mild community-acquired pneumonia in patients older than 60 years in hospital has been evaluated. Analyzed 71 case histories. The assessment was carried out on the basis of a comprehensive analysis of clinical, laboratory and radiological data. A comparative analysis of the clinical efficacy and safety of the antibiotic regimens under study demonstrated the obvious advantage of using «protected» aminopenicillins over the existing practice of treating non-severe community-acquired pneumonia in patients of older age groups.
作者简介
I Kulagina
Главный военный клинический госпиталь им. Н.Н.Бурденко
Email: irina-kulagina@mail.ru
Москва
V Likhodii
Главный военный клинический госпиталь им. Н.Н.БурденкоМосква
A Zaitsev
Главный военный клинический госпиталь им. Н.Н.БурденкоМосква